Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women.

Mitochondria generate oxygen-derived free radicals that damage mitochondrial DNA (mtDNA) as well as nuclear DNA and in turn promote carcinogenesis. The mtDNA G10398A polymorphism alters the structure of Complex I in the mitochondrial electron transport chain, an important site of free radical production. This polymorphism is associated with several neurodegenerative disorders. We hypothesized that the 10398A allele is also associated with breast cancer susceptibility. African mitochondria harbor the 10398A allele less frequently than Caucasian mitochondria, which predominantly carry this allele. Mitochondrial genotypes at this locus were therefore determined in two separate populations of African-American women with invasive breast cancer and in controls. A preliminary study at Vanderbilt University (48 cases, 54 controls) uncovered an association between the 10398A allele and invasive breast cancer in African-American women, [odds ratio (OR), 2.90; 95% confidence interval (95% CI), 0.61-18.3; P = 0.11]. We subsequently validated this finding in a large, population-based, case-control study of breast cancer, the Carolina Breast Cancer Study at the University of North Carolina (654 cases, 605 controls). African-American women in this study with the 10398A allele had a significantly increased risk of invasive breast cancer (OR, 1.60; 95% CI, 1.10-2.31; P = 0.013). The 10398A allele remained an independent risk factor after adjustment for other well-accepted breast cancer risk factors. No association was detectable in white women (879 cases, 760 controls; OR, 1.03; 95% CI, 0.81-1.31; P = 0.81). This study provides novel epidemiologic evidence that the mtDNA 10398A allele influences breast cancer susceptibility in African-American women. mtDNA polymorphisms may be underappreciated factors in breast carcinogenesis.

[1]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[2]  S. Leal,et al.  Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. , 2006, Cancer research.

[3]  T. Lehtimäki,et al.  A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects , 2005, European Journal of Human Genetics.

[4]  John A. Hall,et al.  mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Beth Newman,et al.  Comparative analysis of breast cancer risk factors among African-American women and White women. , 2005, American journal of epidemiology.

[6]  L. Newman,et al.  Breast cancer in African-American women. , 2005, The oncologist.

[7]  R. Millikan,et al.  Mitochondrial DNA G 10398 A Polymorphism and Invasive Breast Cancer in African-American Women , 2005 .

[8]  L. Murri,et al.  Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? , 2004, Neuroscience Letters.

[9]  Z. Djuric,et al.  Effects of Low-Fat and/or High Fruit-and-Vegetable Diets on Plasma Levels of 8-Isoprostane-F2α in the Nutrition and Breast Health Study , 2004, Nutrition and cancer.

[10]  J. Gilbert,et al.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk , 2004, Neuroscience Letters.

[11]  Douglas Easton,et al.  The Genetic Epidemiology of Breast Cancer Genes , 2004, Journal of Mammary Gland Biology and Neoplasia.

[12]  H. Soininen,et al.  Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia , 2004, Human Genetics.

[13]  L. Pianese,et al.  Mitochondrial DNA haplogroups influence the Friedreich’s ataxia phenotype , 2004, Journal of Medical Genetics.

[14]  N. Roodi,et al.  Association of Homozygous Wild-Type Glutathione S-Transferase M1 Genotype with Increased Breast Cancer Risk , 2004, Cancer Research.

[15]  J. Haines,et al.  Increased Prevalence of the HFE C282Y Hemochromatosis Allele in Women with Breast Cancer , 2004, Cancer Epidemiology Biomarkers & Prevention.

[16]  Marty C. Brandon,et al.  Effects of Purifying and Adaptive Selection on Regional Variation in Human mtDNA , 2004, Science.

[17]  R. Millikan,et al.  HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites , 2003, Breast Cancer Research and Treatment.

[18]  R. Millikan,et al.  Tumor characteristics in African American and white women , 2001, Breast Cancer Research and Treatment.

[19]  P. Moorman,et al.  Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry , 1995, Breast Cancer Research and Treatment.

[20]  R. Millikan,et al.  The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology , 1995, Breast Cancer Research and Treatment.

[21]  R. Millikan,et al.  Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case–control study of African Americans and whites , 2004, Breast Cancer Research.

[22]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[23]  N. Hamasaki,et al.  Mitochondrial Oxidative Stress and Mitochondrial DNA , 2003, Clinical chemistry and laboratory medicine.

[24]  S. Dimauro,et al.  Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.

[25]  J. Haines,et al.  Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. , 2003, American journal of human genetics.

[26]  Thomas A Trikalinos,et al.  Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.

[27]  Marty C. Brandon,et al.  Natural selection shaped regional mtDNA variation in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Schapira,et al.  Mitochondrial involvement in Parkinson’s disease , 2002, Neurochemistry International.

[29]  K. Majamaa,et al.  Mitochondrial DNA polymorphisms associated with longevity in a Finnish population , 2002, Human Genetics.

[30]  J. Hopper,et al.  Genetic epidemiology of female breast cancer. , 2001, Seminars in cancer biology.

[31]  Derek Middleton,et al.  Mitochondrial DNA polymorphism: its role in longevity of the Irish population , 2001, Experimental Gerontology.

[32]  G. Gururaj,et al.  Hunting genes in Parkinson's disease from the roots. , 2001, Medical hypotheses.

[33]  J. Liehr,et al.  Role of iron in estrogen-induced cancer. , 2001, Current medicinal chemistry.

[34]  J. T. Wachsman,et al.  Mitochondrial DNA in human malignancy. , 2001, Mutation research.

[35]  K. Marder,et al.  Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease , 2000, Neurology.

[36]  D. Wallace,et al.  Mitochondrial DNA variation in human evolution and disease. , 1999, Gene.

[37]  J. Smeitink,et al.  Human mitochondrial complex I in health and disease. , 1999, American journal of human genetics.

[38]  D. Wallace Mitochondrial diseases in man and mouse. , 1999, Science.

[39]  N. Vermeulen,et al.  Biomarkers of free radical damage applications in experimental animals and in humans. , 1999, Free radical biology & medicine.

[40]  N. Roodi,et al.  Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. , 1998, Cancer research.

[41]  D. Charron,et al.  Mitochondrial Genotype Associated with French Caucasian Centenarians , 1998, Gerontology.

[42]  B. Robinson Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. , 1998, Biochimica et biophysica acta.

[43]  R. Millikan,et al.  Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  L. Cavalli,et al.  Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? , 1998, Mutation research.

[45]  K. Yagi,et al.  Mitochondrial genotype associated with longevity , 1998, The Lancet.

[46]  H. Ohshima,et al.  Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. , 1998, Free radical biology & medicine.

[47]  C. Fall,et al.  Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.

[48]  D. Wallace,et al.  Mitochondrial DNA in aging and disease. , 1997, Scientific American.

[49]  A. Colell,et al.  Direct Effect of Ceramide on the Mitochondrial Electron Transport Chain Leads to Generation of Reactive Oxygen Species , 1997, The Journal of Biological Chemistry.

[50]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.

[51]  S. Papa Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. , 1996, Biochimica et biophysica acta.

[52]  Yager Jd,et al.  Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .

[53]  J. Yager,et al.  Molecular mechanisms of estrogen carcinogenesis. , 1996, Annual review of pharmacology and toxicology.

[54]  L. Excoffier,et al.  Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. , 1995, American journal of human genetics.

[55]  D. Wallace,et al.  Mitochondrial DNA sequence variation in human evolution and disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Torroni,et al.  Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance , 1994, Journal of bioenergetics and biomembranes.

[57]  L. Loeb,et al.  Reactive oxygen species in tumorigenesis. , 1994, Cancer research.

[58]  B. Crain,et al.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.

[59]  C R Weinberg,et al.  Randomized recruitment in case-control studies. , 1991, American journal of epidemiology.

[60]  W. Dupont,et al.  Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.

[61]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[62]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[63]  D. Roy,et al.  Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. , 1989, Cancer research.

[64]  B. Ames,et al.  Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[65]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[66]  Rascon [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.